
Alembic Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated November 04, 2025, titled "Revised Press Release for the Q2 FY 26 Results".
Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated November 04, 2025, titled "Revised Press Release for the Q2 FY 26 Results".
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals